Annual European Futbol Pharmacometrics Collective Live Events Annual European Futbol Pharmacometrics Collective Date: Wednesday, June 4Time: 6:00 PM – 10:00 PMLocation: Football Sport Center — 47 Poseidonos…CertaraMay 1, 2025
A translational model-based meta-analysis to predict tremor incidence associated with serotonin reuptake transporter inhibition Publication A translational model-based meta-analysis to predict tremor incidence associated with serotonin reuptake transporter inhibition The serotonin reuptake transporter (SERT) is responsible for the removal and recycling of the neurotransmitter…CertaraApril 30, 2025
Clinical validation of a quantitative systems pharmacology (QSP) model of ISB 2001 used for deriving first in human (FIH) dose and efficient phase 1 dose escalation design in relapsed/refractory multiple myeloma (RRMM) patient Poster Clinical validation of a quantitative systems pharmacology (QSP) model of ISB 2001 used for deriving first in human (FIH) dose and efficient phase 1 dose escalation design in relapsed/refractory multiple myeloma (RRMM) patient In partnership with Ichnos, Certara developed a QSP model to determine the most suitable therapeutic…CertaraApril 30, 2025
Non-Animal Navigator™: Expert strategy and AI-enabled biosimulation to reduce, refine, or replace animal studies Fact Sheet Non-Animal Navigator™: Expert strategy and AI-enabled biosimulation to reduce, refine, or replace animal studies Certara’s Non-Animal Navigator™ solution helps companies adapt by selecting and optimizing the best-fit NAM strategies.CertaraApril 30, 2025
Combining mechanistic modeling with machine learning to predict clinical scores in inflammatory bowel disease (IBD) On-Demand Webinar Combining mechanistic modeling with machine learning to predict clinical scores in inflammatory bowel disease (IBD) Learn how QSP, virtual patients, and machine learning come together to transform IBD drug development.…CertaraApril 29, 2025
Certara to Participate in Upcoming Investor Conferences Press Release Certara to Participate in Upcoming Investor Conferences RADNOR, PA — April 29, 2025 -- Certara, Inc. (Nasdaq: CERT), a global leader in…CertaraApril 29, 2025
Rare disease drug development: challenges, support and hopes for the future Press Coverage Rare disease drug development: challenges, support and hopes for the future Explore rare disease drug development challenges, biosimulation solutions, and IRDiRC's significant role in transforming the…CertaraApril 29, 2025
Outsourcing in Clinical Trials East Coast 2025 Conference Outsourcing in Clinical Trials East Coast 2025 - - BoothCertaraApril 28, 2025
Interactions of Therapeutic Antibodies With Presynaptically-Released Misfolded Proteins in Neurodegenerative Diseases. A Spatial Monte-Carlo Simulation Study Publication Interactions of Therapeutic Antibodies With Presynaptically-Released Misfolded Proteins in Neurodegenerative Diseases. A Spatial Monte-Carlo Simulation Study The spatial progression hypothesis of misfolded tau and alpha-synuclein proteins in Alzheimer's and Parkinson's Disease…CertaraApril 28, 2025
RAPS Sponsored Webcast: Regulatory Writing and Operations to Accelerate Submissions On-Demand Webinar RAPS Sponsored Webcast: Regulatory Writing and Operations to Accelerate Submissions Senior Director, Regulatory Operations and Clinical Disclosure, Certara A seasoned pharmaceutical industry veteran, Evans Richardson…CertaraApril 24, 2025